Physician profile
Efrain Perez
NPI 1437250131
$9,460.69
in general payments reported to CMS, 2019-2025
51 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $517 · 2020: $256 · 2021: $1,877 · 2022: $991 · 2023: $2,969 · 2024: $2,535 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,549 · Food and Beverage: $2,164 · Education: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,548.99 |
| Food and Beverage | $2,163.85 |
| Education | $107.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,095.21 | 2024 | |
| Medical Device Business Services, INC. | $1,076.95 | 2023 | Enseal |
| Lsi Solutions INC | $989.95 | 2023 | Fornisee |
| Coloplast Corp | $935.64 | 2021-2024 | |
| Abbvie INC. | $881.27 | 2019-2023 | |
| Astellas Pharma US INC | $428.00 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $347.38 | 2022-2025 | |
| Daiichi Sankyo INC. | $337.18 | 2019-2023 | Injectafer |
| Novo Nordisk INC | $224.22 | 2019-2024 | Wegovy |
| Pfizer INC. | $179.51 | 2021-2025 | |
| Myriad Women'S Health, INC. | $156.03 | 2023 | Myrisk |
| Therapeuticsmd, INC. | $150.57 | 2019-2021 | |
| Evofem Biosciences, INC. | $121.72 | 2021-2025 | Phexxi, Solosec, Phexx |
| Agile Therapeutics, INC. | $114.33 | 2021-2024 | Twirla |
| Organon LLC | $110.26 | 2021-2025 | Nexplanon |
Show all 51 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Efrain Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.